Skip to main content

JANE STREET GROUP, LLC

Position in BIOA — BioAge Labs, Inc.

CIK 1595888 NEW YORK, NY

Position in BIOA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$590,421
+$590,421 QoQ
Shares Held
24,089
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 151 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Derivatives in BIOA

reported options exposure · as of Jun 30, 2026
CallValue
$335,787
CallShares
13,700
PutValue
$409,317
PutShares
16,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $557,642,679 across 56 Drug Manufacturers - Specialty & Generic names. BIOA ranks #25 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BIOA

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $335,787 13,700
2026-06-30 $409,317 16,700
2026-06-30 $590,421 24,089
2026-03-31 $271,095 15,500
2026-03-31 $190,641 10,900
2025-12-31 $244,755 18,500
2024-09-30 $895,918 43,073